Skip to main content
logo
SpringWorks Therapeutics, Inc. (SWTX)
Jul 1, 2025 - SWTX was delisted (reason: acquired by Merck KGaA)
46.99
0.00 (0.00%)
Inactive · Last trade price on Jun 30, 2025

SpringWorks Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
3,5412,6872,6821,6163,0203,476
Market Cap Growth
-0.18%65.95%-46.48%-13.11%109.99%
Enterprise Value
3,1652,1962,2679702,5413,199
Last Close Price
46.9936.1336.5026.0161.9872.52

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
15.9214.02492.39--99.31
PB Ratio
8.445.594.282.907.156.24
P/TBV Ratio
8.485.774.362.907.156.24

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/Sales Ratio
14.4111.46416.18--91.40

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
0.020.020.010.010.000.01
Asset Turnover
0.380.290.01--0.08
Inventory Turnover
1.691.89----
Quick Ratio
3.993.546.2111.6012.4628.88
Current Ratio
4.333.816.4111.7512.7829.15
Return on Equity (ROE)
-51.57%-46.62%-54.90%-56.58%-35.51%-10.37%
Return on Assets (ROA)
-28.47%-26.48%-31.62%-32.40%-21.08%-6.36%
Return on Invested Capital (ROIC)
-33.13%-30.98%-35.83%-35.54%-22.05%-6.57%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-7.17%-9.61%-12.12%-17.16%-5.76%-1.31%
FCF Yield
-4.78%-6.70%-8.58%-10.63%-4.30%-0.95%
Buyback Yield / Dilution
-12.77%-17.44%-18.45%-9.88%-12.00%-226.18%
SEC Filings: 10-K · 10-Q